Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 9 - Medicinal preparations characterised by special physical form
Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044)
10/2003
10/16/2003US20030194413 Methods and compositions employing red rice fermentation products
10/16/2003US20030194412 Emulsion comprising an aqueous phase, an oil phase, and a solvent and an immunogen
10/16/2003US20030194379 Aerosol container and a method for storage and administration of a pre-determined amount of a pharmaceutically active aerosol
10/16/2003US20030194378 Novel aerosol formulation containing a polar fluorinated molecule
10/16/2003US20030194377 Therapeutic uses of BPI protein products in cystic fibrosis patients
10/16/2003US20030194374 High speed dissolve layer when exposed to saliva; drug delivery of orally administrable medicine
10/16/2003US20030193102 Encapsulated agglomeration of microcapsules and method for the preparation thereof
10/16/2003US20030192540 Therapeutic dry powder preparation
10/16/2003US20030192533 New method
10/16/2003CA2708900A1 Pharmaceutical preparation containing oxycodone and naloxone
10/16/2003CA2481377A1 Antihistamine-decongestant pharmaceutical compositions
10/16/2003CA2481025A1 Palatable chewable tablet
10/16/2003CA2480824A1 Oral pharmaceutical formulation in the form of aqueous suspension of microcapsules for modified release of amoxicillin
10/16/2003CA2480790A1 Use of antithrombin iii in treating acute lung injury
10/16/2003CA2480579A1 Embolization
10/16/2003CA2480477A1 Device for intradermal medicament delivery
10/16/2003CA2480476A1 Valved intradermal delivery device
10/16/2003CA2479781A1 Hydrogel adhesives for use on hair or fiber-populated surfaces
10/16/2003CA2479522A1 New pharmaceutical compositions based on anticholinergics and p38 kinase inhibitors
10/16/2003CA2479520A1 P38 kinase inhibitors for treating mucus hypersecretion_
10/16/2003CA2479380A1 Hydrogel adhesives for use on hair or fiber-populated surfaces
10/16/2003CA2478930A1 Epitope constructs comprising antigen presenting cell targeting mechanisms
10/16/2003CA2478523A1 Matrix for sustained, invariant and independent release of active compounds
10/16/2003CA2476545A1 Parenteral, intravenous, and oral administration of oxazolidinones for treating diabetic foot infections
10/16/2003CA2452442A1 Polyfunctional biocompatible hydrogel and method for the production thereof
10/15/2003EP1352955A2 HLA matching donor-originating activated lymphocytes to be used in prevention/treatment of tumors, infectious diseases and autoimmune diseases, treatment method achieved by using the lymphocytes, formula having the lymphocytes as a main constitutuent thereof, method for manufacturing the formula and preparation kit to be used to prepare the formula
10/15/2003EP1352903A1 Preventive or remedial agent for allergic disease and medical water-based liquid preparation, eye drop, and nasal drop
10/15/2003EP1352661A1 Injections for endoscopy
10/15/2003EP1352660A1 Oral pharmaceutical dosage forms comprising a proton pump inhibitor and a nsaid
10/15/2003EP1352654A1 Famotidine injections
10/15/2003EP1352653A1 Dihydrofuran cyclic tanshintones used in treating hyperammonemia and hepatic encephalopathy
10/15/2003EP1352649A2 Patch and production method thereof
10/15/2003EP1352648A1 Pharmaceutical compositions of acetylsalicylic acid and omega-3 oils
10/15/2003EP1352647A1 Controlled-release sedative hypnotic compositions and method related thereto
10/15/2003EP1352646A2 Lozenge containing ambroxol
10/15/2003EP1352645A1 Effervescent compositions containing dried fruit juices
10/15/2003EP1352638A1 Cosmetics
10/15/2003EP1352072A2 Nucleic acid delivery formulations
10/15/2003EP1352061A2 Method for inhibiting the expression of a target gene
10/15/2003EP1351995A2 Production of carrageenan and carrageenan products
10/15/2003EP1351972A1 Lipids comprising an aminoxy group
10/15/2003EP1351760A2 Continuous production of pharmaceutical granulates
10/15/2003EP1351720A1 Hydrocolloid compositions
10/15/2003EP1351710A2 Compositions containing inclusion complexes
10/15/2003EP1351704A2 Storage stable powder compositions of interleukin-4 receptor
10/15/2003EP1351696A2 Composition for delivery of hematopoietic growth factor
10/15/2003EP1351693A1 Novel method and compositions for local treatment of meniere's disease, tinnitus and/or hearing loss
10/15/2003EP1351692A1 Oral formulation comprising an inhibitor compound of the ileal bile transport and an hmg co-a reductase inhibitor
10/15/2003EP1351690A2 Method of treatment of dopamine-related dysfunction through administration of a full d1 dopamine receptor agonist and with no induction of tolerance
10/15/2003EP1351685A2 Stabilized formulation of selective ligands of retinoic acid gamma-receptors
10/15/2003EP1351681A2 Implantable device containing resorbable matrix material and anti-proliferative drugs for preventing or treating failure of hemodialysis vascular access and other vascular grafts
10/15/2003EP1351673A1 Compositions of stable t 3? and methods of use thereof
10/15/2003EP1351669A1 Clear propofol compositions
10/15/2003EP1351668A1 Sustained release pharmaceutical dosage forms with minimized ph dependent dissolution profiles
10/15/2003EP1351667A1 Pharmaceutical composition containing citalopram
10/15/2003EP1351666A1 A method for the preparation of nanoparticles
10/15/2003EP1351623A1 Implantable device
10/15/2003EP1351585A1 Ingestible compositions containing an odoriferous oil
10/15/2003EP1244427B1 Pharmaceutical compositions for oral administration
10/15/2003EP1233758B1 Sodium valproate granulate with reduced hygroscopicity
10/15/2003EP1231909B1 Use of ubiquinone q10 for the local treatment and prevention of post-surgical ophthalmologic pathologies
10/15/2003EP1173181B1 Composition comprising phosphodiesterase inhibitors for the treatment of sexual dysfunction
10/15/2003EP1094796B1 Topical plaster with non-steroidal antirheumatic agents with an acid group
10/15/2003EP0876140B1 Improved kontrast agent solutions for intravenous administration
10/15/2003EP0874558B1 Liquid oral compositions comprising a calcium compound and an acidulant
10/15/2003EP0827398B1 Pharmaceutical dosage form for colonic delivery
10/15/2003EP0797987B1 Sustained-release granular preparation and process for producing the same
10/15/2003EP0771339B1 Dry moisture barrier film coating composition, method of coating substrates using the same and pharmaceutical tablets coated therewith
10/15/2003EP0750494B1 Hydrophobic drug delivery systems
10/15/2003CN1449289A Oct制剂 Oct preparations
10/15/2003CN1449288A Pharmaceutical formulation of salmeterol and fluticasone propionate
10/15/2003CN1449282A Treatment of burns
10/15/2003CN1449281A Medicaments for treating colics
10/15/2003CN1449280A Rapidly-decomposing administrable form for releasing active ingredients in the oral cavity or in bodily cavities
10/15/2003CN1449279A Cross-linked high amylose starch for use in controlled-release pharmaceutical formulations and processes for its manufacture
10/15/2003CN1449278A Lung surfactant compositions with dynamic swelling behaviour
10/15/2003CN1449273A Antimicotic nail varnish composition
10/15/2003CN1449272A 硬胶囊 Hard Capsules
10/15/2003CN1449270A Topical compositions containing prostaglandin e1
10/15/2003CN1448420A Hydrophilic polymer and tanshinones medicine conjugation agent and medicine composition containing same
10/15/2003CN1448184A Injectable pharmaceutical composition containing non-steroid antiphlogistic medicament and method for making same
10/15/2003CN1448173A Cymose buckwheat rhizome preparation,production method and use thereof
10/15/2003CN1448171A Blood sugar and glucose in urine lowering capsule
10/15/2003CN1448162A Female external sterilization film
10/15/2003CN1448156A Garlic and lucid ganoderma extract capsule and its prepn. method
10/15/2003CN1448153A Ointment for treating dermatopathy and preparing process thereof
10/15/2003CN1448146A 珍珠混悬液 Pearl suspension
10/15/2003CN1448138A Artesunate and dihydroarteannuin medicine preparation for proofing formation of blood vessel and use thereof
10/15/2003CN1448137A Gatifloxacin external and ophthalmic gel preparation
10/15/2003CN1448132A Modified antineoplastic preparation based on Paclitaxel
10/15/2003CN1448131A Medicine composition containing alpha-pinene and 1,8-eucalyptol fever-tree oil and use thereof
10/15/2003CN1448129A Garlicin and garlic oil cyclodextrin derivatives inclusion compound and method for making same
10/15/2003CN1448128A Process for producing nanoparticles of paclitaxel and albumin
10/15/2003CN1448123A Non-spherical and non-platelet pyrithione salts
10/15/2003CN1448122A Oil-in-water type cosmetics
10/15/2003CN1448121A O/W/O type polyphase emulsion
10/15/2003CN1448120A W/O/W type polyphase emulsion
10/15/2003CN1448117A Nano plaster containing far infrared material and magnetic powder
10/15/2003CN1124352C Oligosaccharide-supplying compositions
10/15/2003CN1124157C Pharmaceutical compositions
1 ... 2081 2082 2083 2084 2085 2086 2087 2088 2089 2090 2091 2092 2093 2094 2095 2096 2097 2098 2099 2100 2101 ... 2991